A NEW ANTIBACTERIAL AGENT FOR WOUND MANAGEMENT PRODUCTS: POSTBIOTICS FROM STAPHYLOCOCCUS HOMINIS EIR/HS-1, AN ISOLATE FROM HUMAN SKIN MICROBIOTA


Kıran F., Omeroglou E., Kibar Demirhan H.

European Wound Mangagement Association 2024, London, İngiltere, 1 - 03 Mayıs 2024, ss.1

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: London
  • Basıldığı Ülke: İngiltere
  • Sayfa Sayıları: ss.1
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: This study aims to isolate bacteria originating from human skin microbiota and determine their potential antibacterial effects against clinically important skin pathogens.

 

Method: Swab samples from healthy human skin (n=22) were plated on MRS agar and incubated until colonies were observed. From each plate, phenotypically distinct colonies (n=102) were picked onto fresh media. Their antibacterial activity was determined by agar well-diffusion assay against clinically important skin pathogens. The most effective isolate which exhibited a remarkable inhibitory effect against all tested pathogens was selected and identified by molecular methods. Postbiotics of the isolate were obtained following the fermentation process. The minimum inhibitory concentration (MIC) against all tested pathogens was determined by microtiter plate assay. Anti-biofilm activity was evaluated by crystal violet staining. Quorum sensing-related gene expressions were analyzed using RT-PCR.

 

Results / Discussion:  The selected isolate was identified Staphylococcus hominis according to its 16S rRNA gene region (1.492 bp) sequencing.  Postbiotics displayed an antibacterial effect against all tested pathogens and their sub-MIC value eradicated their biofilm production. It was also proven that the gene expression levels related to the quorum signal transduction system were significantly down-regulated in a dose-dependent manner.

 

Conclusion:  This study highlights the potential effects of postbiotics against important skin pathogens and demonstrates their multifaceted roles in wound healing.